Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Army
McKesson
QuintilesIMS
Healthtrust
Boehringer Ingelheim
Deloitte
Cerilliant
Accenture
AstraZeneca

Generated: February 16, 2019

DrugPatentWatch Database Preview

BENLYSTA Drug Profile

« Back to Dashboard

Summary for Tradename: BENLYSTA
Patents:33
Applicants:1
BLAs:1
Suppliers: see list1
Pharmacology for BENLYSTA
Mechanism of ActionB Lymphocyte Stimulator-directed Antibody Interactions
Physiological EffectDecreased B Lymphocyte Activation

US Patents for BENLYSTA

Glossary
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Human Genome Sciences Inc. BENLYSTA belimumab INJECTABLE; INJECTION 125370 001 2011-03-09 ➤ Try a Free Trial The United States of America, as represented by the Secretary, Department of Health & Human Services (Washington, DC) ➤ Try a Free Trial RX search
Human Genome Sciences Inc. BENLYSTA belimumab INJECTABLE; INJECTION 125370 001 2011-03-09 ➤ Try a Free Trial CureVac AG (Tubingen, DE) ➤ Try a Free Trial RX search
Human Genome Sciences Inc. BENLYSTA belimumab INJECTABLE; INJECTION 125370 001 2011-03-09 ➤ Try a Free Trial Exagen Diagnostics, Inc. (Vista, CA) ➤ Try a Free Trial RX search
Human Genome Sciences Inc. BENLYSTA belimumab INJECTABLE; INJECTION 125370 001 2011-03-09 ➤ Try a Free Trial Genentech, Inc. (South San Francisco, CA) ➤ Try a Free Trial RX search
Human Genome Sciences Inc. BENLYSTA belimumab INJECTABLE; INJECTION 125370 001 2011-03-09 ➤ Try a Free Trial Aegis Therapeutics LLC (San Diego, CA) ➤ Try a Free Trial RX search
Human Genome Sciences Inc. BENLYSTA belimumab INJECTABLE; INJECTION 125370 001 2011-03-09 ➤ Try a Free Trial biOasis Technologies, Inc. (Vancouver, British Columbia, unknown) ➤ Try a Free Trial RX search
Human Genome Sciences Inc. BENLYSTA belimumab INJECTABLE; INJECTION 125370 001 2011-03-09 ➤ Try a Free Trial Natrogen Therapeutics International, Inc. (New York, NY) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Teva
McKinsey
Baxter
Express Scripts
Fish and Richardson
Merck
AstraZeneca
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.
Links

Follow DrugPatentWatch: